---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-000525"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2026-01-06T23:59:59+00:00"
generated_at: "2026-05-16T11:36:44.710092+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# LifeMD closes $50M revolving credit facility with Citizens Bank, N.A.

## Summary
- Facility provides $30M committed plus $20M accordion; maturity January 2, 2029.
- No amount drawn at closing; Company cites sufficient cash flow for organic growth.
- Interest based on Term SOFR + 1.50%-2.25% or ABR + 0.50%-1.25%; commitment fee 0.225%-0.30%.
- No upfront fee; credit supports corporate development and shareholder value initiatives.
- Financial covenants: leverage ratio ≤2.50x, interest coverage ≥3.00x.

## SEC filing metadata
- accession: 0001493152-26-000525
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2026-01-06T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000149315226000525/0001493152-26-000525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000149315226000525/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-000525
- JSON: https://secwatch.observer/filing/0001493152-26-000525.json
- Plain text: https://secwatch.observer/filing/0001493152-26-000525.txt

## Key facts
- Debt Financings
  LifeMD, Inc. incurred revolving credit of $30 million with Citizens Bank, N.A. at Term SOFR plus 1.50% to 2.25% or Alternate Base Rate plus 0.50% to 1.25% maturing January 2, 2029.
  - Instrument: revolving credit
  - Principal: $30 million
  - Counterparty: Citizens Bank, N.A.
  - Rate: Term SOFR plus 1.50% to 2.25% or Alternate Base Rate plus 0.50% to 1.25%
  - Maturity: January 2, 2029
  - Event: incurrence
  source text: On January 2, 2026, LifeMD, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with Citizens Bank, N.A. (the “Lender”), which provides for a senior secured revolving credit facility in an aggregate outstanding amount not exceeding $30 million (the “Credit Facility”) to support potential corporate development and/or shareholder value creation initiatives. The Credit Facility may be increased in the aggregate principal amount of up to $20 million on the terms and subject to the conditions described in the Credit Agreement. In connection with the Credit Agreement, among other things, the Company issued a revolving loan note to the Lender for any loans that may be made under the Credit Facility. Additionally, among other things, the Company and its subsidiaries entered into a pledge and security agreement and a guarantee agreement to provide credit support for the Credit Facility. The Credit Facility matures on January 2, 2029. The terms of the Credit Facility pr
  evidence_url: https://www.sec.gov/Archives/edgar/data/948320/000149315226000525/0001493152-26-000525-index.htm
- Material Agreements
  LifeMD, Inc. entered into Credit Agreement with Citizens Bank, N.A. valued at $30 million (effective 2026-01-02).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Citizens Bank, N.A.
  - Value: $30 million
  - Effective: 2026-01-02
  source text: On January 2, 2026, LifeMD, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”) with Citizens Bank, N.A. (the “Lender”), which provides for a senior secured revolving credit facility in an aggregate outstanding amount not exceeding $30 million (the “Credit Facility”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/948320/000149315226000525/0001493152-26-000525-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.